Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/66710
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Yuste, Laura | - |
dc.contributor.author | Esparís-Ogando, Azucena | - |
dc.contributor.author | Santos de Dios, Eugenio | - |
dc.contributor.author | Pandiella, Atanasio | - |
dc.date.accessioned | 2013-02-15T11:13:12Z | - |
dc.date.available | 2013-02-15T11:13:12Z | - |
dc.date.issued | 2005 | - |
dc.identifier | doi: 10.1093/jb/mvi092 | - |
dc.identifier | issn: 0021-924X | - |
dc.identifier | e-issn: 1756-2651 | - |
dc.identifier.citation | Journal of Biochemistry 137(6): 731-739 (2005) | - |
dc.identifier.uri | http://hdl.handle.net/10261/66710 | - |
dc.description.abstract | Receptor tyrosine kinases of the ErbB family have been implicated in the onset/progression of a number of neoplasias. In these diseases, ErbB receptor expression may be accompanied by constitutive activation caused by molecular alterations, overexpression, or ligand binding. An important signaling route activated by these recep-tors that has been linked to the stimulation of cell proliferation is the Ras route. Here we have investigated the action of a mutant Ras form, H-RasN17, on the proliferation of the breast cancer epithelial cell line MCF7 cells. In these cells expression of RasN17 failed to affect serum or ErbB receptor-stimulated proliferation. Analysis of the action of RasN17 indicated that overexpression of this mutant form of Ras did not affect neuregulin or protein kinase C-induced activation of Erk1/2. In addition, RasN17 failed to prevent activation of endogenous N-Ras and H-Ras even though the levels of the latter were much lower than those of the RasN17 form. The failure of RasN17 to prevent endogenous Ras activation did not appear to be due to deficient processing or sorting of the mutated form. These data indicated that the action of RasN17 as a bona fide inhibitor of Ras depends on the cell type and requires detailed analysis of the biochemical and biological properties of RasN17, particularly with respect to the activation of endogenous Ras. © 2005 The Japanese Biochemical Society. | - |
dc.description.sponsorship | We acknowledge funding from the Instituto de Salud Carlos III through project 01/1060. L.Y. was supported by a predoctoral fellowship from the Ministry of Science and Technology. AEO was supported by the Spanish Association Against Cancer (AECC). | - |
dc.language.iso | eng | - |
dc.publisher | Oxford University Press | - |
dc.rights | closedAccess | - |
dc.title | Overexpression of RasN17 fails to neutralize endogenous ras in MCF7 breast cancer cells | - |
dc.type | artículo | - |
dc.identifier.doi | 10.1093/jb/mvi092 | - |
dc.date.updated | 2013-02-15T11:13:12Z | - |
dc.description.version | Peer Reviewed | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.openairetype | artículo | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
Aparece en las colecciones: | (IMB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
3
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
3
checked on 25-feb-2024
Page view(s)
347
checked on 23-abr-2024
Download(s)
122
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.